loadpatents
name:-0.01195502281189
name:-0.0052139759063721
name:-0.0027520656585693
Campos; Bismarck Patent Filings

Campos; Bismarck

Patent Applications and Registrations

Patent applications and USPTO patent grants for Campos; Bismarck.The latest application filed is for "inhibition of olig2 activity".

Company Profile
2.6.11
  • Campos; Bismarck - San Antonio TX
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Inhibition of OLIG2 activity
Grant 11,242,323 - Beaton , et al. February 8, 2
2022-02-08
Inhibition Of Olig2 Activity
App 20210347739 - BEATON; Graham ;   et al.
2021-11-11
Inhibition Of Olig2 Activity
App 20210253535 - BEATON; Graham ;   et al.
2021-08-19
Inhibition Of Olig2 Activity
App 20210114991 - BEATON; Graham ;   et al.
2021-04-22
Inhibition Of Olig2 Activity
App 20200407329 - BEATON; Graham ;   et al.
2020-12-31
Inhibition Of Olig2 Activity
App 20190389812 - BEATON; Graham ;   et al.
2019-12-26
Inhibition Of Olig2 Activity
App 20180244631 - BEATON; Graham ;   et al.
2018-08-30
Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors
Grant 9,169,220 - McHardy , et al. October 27, 2
2015-10-27
Oximes For Treatment Of Peripheral And Central Nervous System Exposure to Acetyl Cholinesterase Inhibitors
App 20150005328 - MCHARDY; Stanton F. ;   et al.
2015-01-01
Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors
Grant 8,772,345 - McHardy , et al. July 8, 2
2014-07-08
Oximes For Treatment Of Peripheral And Central Nervous System Exposure To Acetyl Cholinesterase Inhibitors
App 20140066421 - McHardy; Stanton F. ;   et al.
2014-03-06
Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors
Grant 8,653,108 - McHardy , et al. February 18, 2
2014-02-18
Oximes For Treatment Of Peripheral And Central Nervous System Exposure To Acetyl Cholinesterase Inhibitors
App 20130035351 - MCHARDY; Stanton F. ;   et al.
2013-02-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed